Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × MK-4166 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Cyclophosphamide 905 Carboplatin 779 Paclitaxel 737 pembrolizumab 718 Bevacizumab 703 Cisplatin 702 Gemcitabine 612 Docetaxel 573 Rituximab 546 Radiotherapy 534 Dexamethasone 506 Nivolumab 473 Doxorubicin 442 Fluorouracil 390 Capecitabine 376 Etoposide 358 Oxaliplatin 332 Cytarabine 331 Pemetrexed 330 Lenalidomide 326 Prednisone 324 fludarabine phosphate 314 Erlotinib Hydrochloride 313 Trastuzumab 297 Leucovorin 296 fludarabine 294 Vincristine 286 Filgrastim 283 Bortezomib 283 Cetuximab 271

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡